Clinical Trials · NCT04324229

Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes

Name: Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedN/ALiraglutide

Phase: N/A
Recruitment status: Completed
Sponsor: Turku University Hospital
Enrollment: 67
Start date: Feb 2020
Locations: 1 site, Finland
Primary endpoint: Incidence of type 2 diabetes

View Liraglutide compound reference